Collaboration aims to strengthen cell and gene therapy education.

  • Made Scientific partners with NJIT for improved curriculum
  • Focus on cell and gene therapy bioprocessing education
  • Enhancing graduate-level training in emerging fields

Made Scientific has entered a partnership with the New Jersey Institute of Technology (NJIT) to enhance cell and gene therapy education at the graduate level. This collaboration focuses on improving the curriculum specifically in bioprocessing, an essential area within this rapidly advancing field. The initiative aims to equip students with the necessary skills to meet the increasing demand for professionals in cell and gene therapy.

The partnership will leverage NJIT's expertise and resources in technology and engineering to provide students with in-depth knowledge and hands-on training. By integrating industry practices and academic learning, the collaboration seeks to elevate the educational experience for future graduates. Students will benefit from a curriculum designed to tackle real-world challenges in bioprocessing, preparing them for impactful careers in the biotechnology industry.

This initiative comes at a crucial time as the cell and gene therapy sectors continue to evolve and expand. Enhanced education and training will play a significant role in addressing the growing workforce needs in these innovative fields. Together, Made Scientific and NJIT aim to foster new talent capable of driving advancements in health technology.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

HelpMeSee Unveils Next-Generation MSICS Training System at SAFO

New training system aims to improve global solutions for blindness. HelpMeSee launches…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…